Dedicated to Finding New Medicines Through Targeting the Ubiquitin Pathway

News Headlines


Dr. Tauseef Butt, President and CEO, spoke at a recent Cambridge Healthtech Institute conference on small molecules, specifically inhibitors of ubiquitin protease 7 (USP7), and their role in immune oncology. Listen to the podcast here.

Learn More >


Upcoming Meetings

Dr. Suresh Kumar, Senior Director and Head of Drug Discovery, will speak at Cambridge Healthtech Institute’s 2nd Annual Small Molecules for Cancer Immunotherapy, April 4-5, 2018. He will speak on “Targeting the Tumor Microenvironment with Deubiquitinase Inhibitors for Cancer Immunotherapy”.

Learn More >


Business Development

Progenra is seeking industry partnerships for licensing opportunities surrounding the company’s small molecule portfolio Drug Discovery Platform


Learn More >